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Abstract
Objectives—Resting EEG is sensitive to transient, acute effects of nicotine administration and 
abstinence, but the chronic effects smoking on EEG are poorly characterized. This study measures 
the resting EEG profile of chronic smokers in a non-deprived, non-peak state to test whether 
differences in smoking behavior and personality traits affect pharmaco-EEG response.
Methods—Resting EEG, impulsiveness, and personality measures were collected from daily 
smokers (n=22), nondaily smokers (n=31), and non-smokers (n=30).
Results—Daily smokers had reduced resting delta and alpha EEG power and higher 
impulsiveness (Barratt Impulsiveness Scale) compared to nondaily smokers and non-smokers. 
Both daily and nondaily smokers discounted delayed rewards more steeply, reported lower 
conscientiousness (NEO-FFI) and reported greater disinhibition and experience seeking (Sensation 
Seeking Scale) than non-smokers. Nondaily smokers reported greater sensory hedonia than 
nonsmokers.
Conclusions—Altered resting EEG power in daily smokers demonstrates differences in neural 
signaling that correlated with greater smoking behavior and dependence. Although nondaily 
smokers share some characteristics with daily smokers that may predict smoking initiation and 
maintenance, they differ on measures of impulsiveness and resting EEG power.
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Significance—Resting EEG in non-deprived chronic smokers provides a standard for 
comparison to peak and trough nicotine states and may serve as a biomarker for nicotine 
dependence, relapse risk, and recovery.
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1. Introduction
The majority of smokers meet DSM-IV criteria for dependence, with daily use of multiple 
cigarettes being the most common pattern of use and rapid relapse being the most likely 
outcome of attempts at cessation (Hughes et al., 2004, Donny and Dierker, 2007, Zhu et al., 
2012). Nevertheless, a significant proportion of smokers do so intermittently and do not 
show signs of nicotine dependence, an established diagnostic feature in smoking literature 
and randomized clinical trials that is absent from the DSM-IV/5 diagnostic lexicon (Coggins 
et al., 2009, Baker et al., 2012). The remarkable ability of intermittent smokers to use a 
highly addictive substance without transitioning to nicotine dependence may depend on 
processes that would be of great interest in both prevention and treatment development. 
Consequently, the neurophysiological and personality factors that differentiate these two 
groups of smokers have received increasing interest (Shiffman et al., 2009, Shiffman et al., 
2012, Kvaavik et al., 2014, Rass et al., 2014). The electroencephalogram (EEG) is a measure 
of synchronized neural activity that is particularly promising as a sensitive measure of the 
acute and chronic effects of nicotine use (Lerman et al., 2009). To date, however, most 
studies have focused on the effects of acute nicotine intoxication, rather than on effects of 
chronic use on EEG, and none of these studies have contrasted daily and intermittent (non-
daily) smokers. It is important to consider the resting state EEG of non-deprived smokers to 
more thoroughly understand whether nicotine’s effects on functioning represent transient 
changes due to acute drug effects, reflecting amelioration of withdrawal or reversal of pre-
existing deficits, or more lasting changes (due to chronic smoking).
Nicotine use is likely to impact oscillatory activity that is reflected in the scalp EEG. 
Regular nicotine use can alter the distribution or functionality of brain nicotinic 
acetylcholine receptors (nAChR), which play a significant role in neuronal communication 
within and across brain areas (Kadoya et al., 1994, Ghatan et al., 1998, Mansvelder et al., 
2006, Bertrand, 2010). nAChR modulation of the velocity of action potential conduction, 
which alters the functional timing of electrical activity, may affect excitatory and inhibitory 
neuronal networks involved in thalamocortical transmission, sensorimotor interaction (e.g., 
gamma synchrony), and memory formation (e.g., theta synchrony) (Forgacs and Bodis-
Wollner, 2004, Mansvelder et al., 2006, Kawai et al., 2007, Bertrand, 2010, Rutishauser et 
al., 2010). Preclinical studies have found that systemic low dose nicotine administration 
decreases alpha oscillatory power and enhances beta and gamma power in the cortex and 
VTA of nicotine naïve and experienced freely moving rats (Lenoir and Kiyatkin, 2011, 
Lenoir et al., 2013); higher doses produced a decrease in theta, delta, alpha, and beta-1 
power in nicotine naïve rats (Ferger and Kuschinsky, 1997). Several studies have measured 
non-spontaneous EEG activity by presenting stimuli at different frequencies to evoke EEG 
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synchrony. A study of auditory evoked EEG response in anesthetized, nicotine-naïve rodents 
showed enhanced high frequency (40 Hz) response following nicotine administration, 
attenuation of this response during administration of nicotine and NMDA antagonist MK801 
or nicotine receptor (α4β2) antagonist DHβE, and a reduction of this response with 
administration of MK-801 alone (Sivarao et al., 2013).
Human studies of resting EEG report that smoking or nicotine administration typically 
produces a decrease of slow wave EEG power (i.e., delta, theta, low alpha), and an increase 
of high frequency power (i.e., alpha, beta, gamma) in nicotine-deprived smokers (e.g., 
Mansvelder et al., 2006, Domino et al., 2009, Fisher et al., 2012). In contrast, smoking 
abstinence and withdrawal have been associated with a shift of the normal EEG distribution 
to more power at lower frequencies relative to higher frequencies, referred to as EEG 
deactivation or slowing. Nicotine’s direct and indirect effects on dopaminergic neurons may 
further influence glutamatergic and GABAergic activity, resulting in changes to oscillatory 
activity in cortical circuitry (Ford et al., 2007, Weinberger and Dostrovsky, 2011). 
Dopamine receptor binding has been positively correlated with cigarettes per day and 
nicotine dependence scores (Weerts et al., 2014). Haloperidol antagonism of dopamine D2 
receptors was found to partially block EEG-activating effects of nicotine (i.e., shifting EEG 
distribution to having more power at higher frequencies relative to lower frequencies) and 
alter smoking behavior (Caskey et al., 1999, Walker et al., 2001). Differences in the DRD2-
A1 allele (i.e., D2 expression) have been associated with a greater reduction of EEG power 
during smoking abstinence (Gilbert et al., 2004). Because scalp recorded EEG is primarily 
generated by post-synaptic potentials in the cortex, this technique should be well suited to 
detect changes in oscillatory activity at different frequency ranges.
The only two studies that measured resting EEG in non-deprived chronic smokers were 
underpowered to find effects due to small sample sizes and sparse electrode montages 
(Knott and Venables, 1977, Pickworth et al., 1997). Most previous studies of nicotine effects 
have focused on the pharmaco-EEG profile of acute smoking or nicotine administration. In 
deprived smokers, acute administration produces a shifting from slow wave EEG activity 
associated with relaxed wakefulness or drowsiness (i.e., delta, theta, low alpha) to high 
frequency activity associated with arousal or intense mental/emotional activity (i.e., high 
alpha, beta, gamma), similar to studies of other stimulants (Cook et al., 1995, Knott et al., 
1999, Domino, 2001, Pickworth et al., 2003, Mansvelder et al., 2006). Overnight and longer 
abstinence (3–31 days) from smoking produces consistent reduction in EEG power that is 
associated with decreased alertness, worsened cognitive performance, and concurrent 
withdrawal symptoms (e.g., increased craving for cigarettes, negative affect, appetite 
dysregulation) (Gilbert et al., 2004). Some argue that these changes in neural activity 
represent a normalization of the withdrawal state, rather than enhancement of electrocortical 
activation, citing evidence that EEG activation does not surpass that of non-smokers and that 
non-smokers show no change in slow-wave activity following nicotine administration 
(Knott, 2001). Other studies found increased dominant alpha frequency or regional power 
following nicotine administration in non-smokers, possibly reflecting activation of 
approach/motivational circuitry (Foulds et al., 1994, Fisher et al., 2012).
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Measuring resting EEG in cigarette smokers with different use and dependence profiles in 
comparison with non-smoker controls could reveal a potential biomarker for nicotine 
dependence, yet the effects of smoking and nicotine dependence on resting EEG have not 
been thoroughly investigated. Several studies suggest that resting EEG changes persist past 
early withdrawal states. In two studies, Gilbert and colleagues found that altered EEG power 
spectra did not resolve after 31 days of abstinence (Gilbert et al., 1999, Gilbert et al., 2004). 
Additionally, Gilbert et al. found that higher baseline scores on Fagerström Tolerance 
Questionnaire (Gilbert et al., 1999) and the Fagerström Test for Cigarette Dependence 
(Gilbert et al., 2004) were associated with larger quit-related decreases in EEG power. In 
studies of other drugs, changes in specific frequency bands have been associated with 
individual factors, such as drug use frequency, dependence, family history of alcoholism, 
and elevated feelings of euphoria (Parvaz et al., 2011). Finn and Justus (1999) found that 
alpha EEG power was reduced in non-alcoholic offspring of an alcoholic parent, suggesting 
decreased alpha power may reflect risk for alcohol use disorder and possibly other substance 
use disorders (Finn and Justus., 1999). EEG studies of abstinent alcohol-dependent 
participants suggest that a greater presence of higher frequency beta activity, representing 
hyper-arousal of the central nervous system, corresponds with quantity and frequency of 
alcohol intake and can distinguish between ‘low’ and ‘moderate’ drinkers and between 
abstinent and relapse-prone alcoholic individuals (Saletu-Zyhlarz et al., 2004, Parvaz et al., 
2011).
Both resting EEG response and smoking behavior may be associated with addiction-related 
personality traits. Approach-related (e.g., extraversion, novelty seeking, and impulsivity) 
and avoidance-related (e.g., neuroticism and harm-avoidance) traits have been associated 
with smoking initiation, progression, and persistence behavior (Terracciano and Costa, 
2004, Munafo et al., 2007, Iacono et al., 2008, de Wit, 2009). A behavioral measure of 
impulsive decision-making, the delay discounting task, has demonstrated a greater 
preference for smaller, more immediate rewards over larger, delayed rewards (i.e., steeper 
discounting) in smokers vs. non-smokers. Preference for immediate reward has been 
positively correlated with impulsivity, substance abuse history, and higher smoking rates 
and dependence (Bickel et al., 1999, Kirby et al., 1999, Mitchell, 1999, Reynolds, 2004, 
Ohmura et al., 2005, Heyman and Gibb, 2006, Johnson et al., 2007, Sweitzer et al., 2008, 
Rezvanfard et al., 2010). Resting EEG findings measuring the association between cortical 
arousal and personality traits (e.g., introversion/extraversion and impulsiveness) have been 
mixed (Stough et al., 2001, Tran et al., 2001, Knyazev et al., 2002, Schmidtke et al., 2004, 
Houston and Stanford, 2005, Koehler et al., 2011). In one study, greater beta and gamma 
power responses were correlated with higher impulsiveness and addiction severity in 
participants with Internet addition (Choi et al., 2013).
Understanding resting EEG differences in non-deprived smokers is important for more 
accurately interpreting the acute effects of smoking or nicotine administration, acute and 
long-term nicotine withdrawal, and success of smoking intervention or cessation. The 
purpose of this study was to investigate resting EEG response in smokers (daily, nondaily) 
and non-smokers, and measure personality characteristics and impulsiveness as potential 
factors influencing EEG response and smoking status. Smokers were hypothesized to have 
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altered EEG power spectra and higher scores on measures of impulsiveness and sensation 
seeking compared to nonsmokers.
2. Methods
2.1 Participants
Thirty non-smokers, 31 nondaily smokers, and 22 daily dependent smokers were recruited 
from the local community surrounding Indiana University and paid for participation. 
Participants were recruited as part of a study on nondaily smokers; additional methods and 
results are reported elsewhere (Rass et al., 2014). Groups were classified according to the 
following criteria. Non-smokers 1) smoked <10 cigarettes in their lifetime; and 2) had not 
smoked in the past month. Nondaily smokers 1) smoked for ≥3 years; 2) smoked <27 days 
per month for the past 6 months; and (3) in the preceding 90 days, smoked on ≥10 days or 
smoked ≥20 cigarettes. Daily smokers 1) smoked daily for ≥12 months; and 2) showed at 
least moderate dependence (scored ≥4 on the Fagerström Test for Cigarette Dependence, 
FTCD; Agrawal et al., 2011, Fagerström, 2012). Ex-smokers and participants currently 
attempting to quit were not eligible for the study. Participants were excluded for a history of 
electroconvulsive therapy, neurological illness or serious head trauma (including loss of 
consciousness >5 minutes), current anxiety disorder or major depression, use of 
psychotropic medications, and current/past drug abuse/dependence (excluding nicotine) 
based on DSM-IV criteria. Additional exclusion criteria included marijuana use of more 
than once per week and consumption of more than 14 alcoholic drinks per week for males 
and 7 drinks per week for females. All non-smokers were right-handed; two nondaily 
smokers and three daily smokers were left-handed, and one nondaily smoker and one daily 
smoker were ambidextrous. Participants received detailed information about the study 
protocol and gave oral and written informed consent. The Indiana University Institutional 
Review Board approved the study.
2.2 Procedure
2.2.1 Interviews—To determine eligibility, participants completed phone screens, which 
included questions about smoking behavior and the FTCD questionnaire. Study eligibility 
was confirmed in the laboratory using the demographics and screening module of the 
Structured Clinical Interview for Axis-I disorders (SCID-I; First et al., 1997), with follow-up 
questions from additional modules when necessary. Study self-report questionnaires were 
mailed to eligible individuals, and participants completed them prior to or after the lab 
session. Daily smokers were allowed to smoke prior to the EEG recording; their blood-
nicotine levels stabilized during 30–45 minutes of set-up (Benowitz et al., 1988).
2.2.2 Smoking Dependence—Several standard and widely used self-report measures of 
nicotine dependence were administered prior to the EEG procedure. Nicotine dependence 
was measured using the Nicotine Dependence Syndrome Scale (NDSS; Shiffman et al., 
2004). Smoking motives were measured using the Wisconsin Index of Smoking Dependence 
Motives (WISDM; Smith et al., 2010). The Physical Anhedonia Scale assessed capacity to 
experience pleasure from natural reinforcers (i.e., physical sensation), with higher scores 
indicating greater anhedonia (PAS; Chapman LJ, Chapman JP. Revised physical anhedonia 
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scale. Unpublished test. 1978). Current nicotine withdrawal (Wisconsin Smoking 
Withdrawal Scale, WSWS; Hendricks et al., 2006) and breath carbon monoxide (CO; piCO
+, Bedfont Scientific Ltd.) were measured before and after the testing session.
2.2.3 Electrophysiological Assessment
2.2.3.1 Procedure: The electroencephalogram (EEG) was sampled continuously (1000 Hz 
sampling rate, 0.1–200 Hz bandpass filter) from 34 Ag/AgCl electrodes that were mounted 
in a cap (EasyCap, GmbH) and referenced to the nose (Gilbert et al., 2000). Resting EEG 
was recorded in a sound-attenuated room for three minutes during eyes closed and three 
minutes during eyes open conditions. Two electrodes that were placed above and below the 
participant’s left eye recorded bipolar vertical electrooculogram (vEOG). Neuroscan 
SynAmps I digitized the EEG. Electrode impedances were maintained at <10 kOhm.
2.2.3.2 EEG Off-line Processing: The recordings were segmented into two-second epochs, 
baseline corrected for the entire epoch, and corrected for ocular artifacts (Gratton et al., 
1983). Epochs with voltage exceeding ±100 μV at any site were automatically excluded 
from further analyses. Power spectra used to measure signal power (in μV2) were calculated 
by applying Fast Fourier Transform (FFT) to the EEG. The transformed epochs were 
averaged and then exported as the average value for each frequency band: Delta (1.5–3.5 
Hz), Theta (4–7.5 Hz), Alpha (8–12.5 Hz), Beta (13–25 Hz) and Gamma (30–45 Hz) (Barry 
et al., 2011). Power values were averaged across 28 electrode sites: left anterior (F7, F3, 
FT7, FC3, C3), left posterior (P7, P3, PO7, PO3, O1), right anterior (F8, F4, FT8, FC4, C4), 
right posterior (P8, P4, PO8, PO4, O2), midline anterior (FPz, Fz, FCz, Cz) and midline 
posterior (CPz, Pz, POz, Oz). Participants with fewer than 20 accepted epochs were 
excluded from analysis: a) three non-smokers and three nondaily smokers from the eyes 
closed condition and b) two non-smokers and one daily smoker from the eyes open 
condition. Participants with EEG power >4 SD from the sample mean in at least one 
frequency condition were excluded from analysis: a) two non-smokers and one nondaily 
smoker from the eyes open condition.
2.2.4 Personality and Impulsiveness Measures—The NEO 5-Factor Personality 
Inventory (NEO; Costa and McCrae, 1992, Terracciano et al., 2008) measured personality 
characteristics. The Barratt Impulsiveness Scale-11 (BIS; Patton et al., 1995) and the 
Sensation Seeking Scale-V (SSS; Zuckerman et al., 1978) measured factors related to 
impulsiveness.
The Delay Discounting Task measured temporal impulsivity and future-oriented decision-
making. In this task, participants were asked to make hypothetical choices about money. 
Stimuli and procedures from a previous study (Ahn et al., 2011) were used. In order to help 
participants get familiarized with the task, participants completed a practice block of six 
trials where they were offered a choice between receiving a smaller, immediate reward (e.g., 
$30 now) or a larger, delayed reward (e.g., $60 in 8 months). Immediately afterwards, the 
discounting task began with an initial choice between an immediate reward ($400 now) and 
a delayed reward ($800) at one of six different delays: 2 weeks, 1 month, 6 months, 1 year, 3 
years, and 10 years. Each delay block consisted of six trials, and order of the delays was 
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randomized for each participant. Across repeated trials within the same delay, the initial 
amount of money available immediately ($400) was adjusted based on a participant’s choice 
with the goal of identifying an indifference point using an adjusting amount procedure 
(Green and Myerson, 2004) continued for six trails within each delay. Once an indifference 
point was identified at a given delay, the smaller, immediate amount was reset to $400 and 
the process was repeated using a new delay to the larger amount ($800).
2.3 Data Analysis
2.3.1 EEG Analysis—One-way analysis of variance (ANOVA) with between-subjects 
factor of group was run for each EEG frequency. Effect size estimates for analysis of 
variance were determined with partial η2 (partial η2 = .01 is a small effect size, .06 is a 
medium effect size, and .14 is large effect size) (Kittler et al., 2007). Eyes closed and eyes 
open conditions were analyzed separately.
2.3.2 Self-report measures—One-way analysis of variance (ANOVA) with between-
subjects factor of group was run for every dependent variable of self-report measures of 
smoking dependence, personality, and impulsiveness. Delay discounting was characterized 
using a single parameter hyperbolic model: V=A/(1+kD), in which a reward of amount A 
received after a given delay D is discounted at an individualized rate k to a subjective value 
V (Mazur, 1987). We used identical procedures from a previous study (Ahn et al., 2011) to 
estimate the discounting rate k. To briefly repeat them here, each participant’s discounting 
rate was estimated by programming a customized R code that searches for the k value 
minimizing the root-mean-square error for all indifference points in six delays. Because the 
distribution of individual-subject k values was non-normal, a natural logarithm 
transformation was used to approximately normalize the distribution of k across participants. 
Participants with inconsistent performance across trials (positive Ln(k)) and a poor model fit 
(root-mean-square-error (RMSE)=347, which was >4 SD from the sample mean), were 
excluded from analysis (n=2 non-smokers). Indifference points were compared using a 
mixed model ANOVA with a within-measures factor of delay (2 weeks, 1 month, 6 months, 
1 year, 3 years, and 10 years) and between-subjects measure of group (non-smokers, 
nondaily smokers, daily smokers). ANOVAs at each delay tested significant interaction 
effects. Fisher’s Least Significant Difference (LSD) tested significant main effects in post-
hoc analysis.
Exploratory Pearson correlations were used to examine relationships between significant 
resting EEG frequencies, smoking behavior among groups, and self-report measures.
3. Results
3.1 Demographics, Smoking Behavior, and Subjective Craving during the Testing Session 
(Table 1)
Groups did not differ by age or sex. Daily smokers completed less education than non-
smokers (LSD p=.001). Daily smokers had higher carbon monoxide (CO) levels than 
nondaily smokers (LSD p<.001) and non-smokers (LSD p<.001) before and after the 
session. CO and withdrawal post-session compared to pre-session accounted for minimal 
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differences in non-smokers compared to daily smokers (LSD p=.011). Daily smokers had a 
greater increase in craving than both nondaily smokers (LSD p=.001) and non-smokers (LSD 
p=.002).
Analysis of smoking self-report measures revealed that daily smokers initiated smoking 
earlier, smoked for a longer duration, and smoked more frequently relative to nondaily 
smokers. Daily smokers also reported higher levels of dependence and drive than nondaily 
smokers. On the NDSS measure of dependence, daily smokers reported significantly more 
drive (F(1,51)=89.70, p<.001), tolerance (F(1,51)=13.06, p=.001) and a trend for continuity 
(F(1,51)=3.47, p=.068) than nondaily smokers. On the WISDM assessment of smoking 
motivation, daily smokers scored higher on primary dependence motives (i.e., automaticity, 
craving, loss of control, tolerance) than nondaily smokers (p’s<.001). Daily smokers also 
scored higher on WISDM secondary dependence motives, associated with auxiliary features 
of dependence, with p’s<.001 on affective enhancement, affiliative attachment, cognitive 
enhancement, cue exposure, sensory properties (p=.013), and weight control (F(1,51)=3.83, 
p=.056) than nondaily smokers. Group differences on the PAS (F(2,79)=5.09, p=.008) 
showed that nondaily smokers reported less physical anhedonia than non-smokers (LSD p=.
002). One non-smoker was excluded from PAS analysis due scoring >4 standard deviations 
(SD) from the sample mean.
3.2. Resting State EEG (Figure 1)
3.2.1 Eyes Closed—A main effect of group for the alpha frequency (F(2,74)=3.254, p=.
044, partial η2 =.081) showed a decreased response in daily smokers (M=2.8, SD=1.8) 
compared to non-smokers (M=4.4, SD=2.1), LSD p=.014. Differences between non-smokers 
and nondaily smokers (M=3.5, SD=2.4) did not reach significance, LSD p=.132. No 
differences were found for other frequencies.
3.2.2 Eyes Open—A main effect of group for the delta frequency (F(2,73)=3.498, p=.035, 
partial η2 =.087) showed a decreased response in daily smokers (M=2.7, SD=1.0) compared 
to nondaily smokers (M=3.6, SD=1.2), LSD p=.014, and non-smokers (M=3.5, SD=1.6), 
LSD p=.038. A trend main effect of group for the theta frequency (F(2,73)=2.921, p=.060, 
partial η2 =.074) was driven by a reduced response in daily smokers compared to the other 
groups (nondaily smokers LSD p=.022; nonsmokers LSD p=.075). No differences were 
found for other frequencies.
3.3 Self-Report Questionnaires (Table 2, Figures 2–5)
3.3.1 NEO-Five Factor Inventory—Post-hoc analyses revealed that both daily smokers 
and nondaily smokers scored lower on conscientiousness than non-smokers (p=.028; p=.
009).
3.3.2 Barratt Impulsiveness Scale—Post-hoc analyses revealed that daily smokers 
scored higher on the motor impulsiveness subscale than non-smokers (LSD p=.002) and 
nondaily smokers (LSD p=.014). Daily smokers scored higher overall than non-smokers 
(LSD p=.008).
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3.3.3 Sensation Seeking Scale—Post-hoc analyses revealed that higher SSS Total 
Score in daily smokers (p=.006) and nondaily smokers (p=.055) compared to non-smokers 
was driven by endorsing more disinhibition (p=.021; p=.004) and experience-seeking (p=.
021; p=.031) items.
3.3.4 Delay Discounting—Repeated measures ANOVA showed a group × delay 
interaction (F(10,390)=2.680, p=.042) and a main effect of delay (F(5,390)=473.524, p<.
001). Post-hoc analysis showed a trend for higher indifference points in daily smokers than 
non-smokers (LSD p=.060). Follow-up ANOVAs found differences at ten years delay 
(F(2,78)=4.032, p=.022) and marginal differences at three years delay (F(2,78)=3.030, p=.
054. At 10 years delay, daily smokers (LSD p=.012) and nondaily smokers (LSD p=.024) 
had higher discounting rates than non-smokers. At 3 years delay, daily smokers (LSD p=.
032) and nondaily smokers (LSD p=.024) had higher discounting rates than non-smokers. 
There was a trend (p=.10) for steeper discounting rates for the smoking groups compared to 
non-smokers (Figure 5). Based on existing literature, we also compared non-smokers with 
all smokers (combining daily and nondaily smokers) using an independent t-test analysis 
(Bickel et al., 1999, Mitchell, 1999, Baker et al., 2003, Reynolds et al., 2004). The analysis 
showed that smokers discounted delayed rewards more steeply than non-smokers 
(t(79)=2.030, p=.046), which is consistent with the previous reports.
3.4 Exploratory Correlations
Pearson correlations explored the relationship between the resting EEG measures that 
differed between groups. Pearson correlation coefficients were computed for resting EEG 
eyes open (delta, theta) and eyes closed (alpha) condition and their relationship with 
smoking variables (smoking duration, cigarettes per week (smoking days per week x CPD), 
CO levels pre-session, FTCD total, NDSS total, WISDM total, and PAS total) for daily and 
nondaily smokers as well as personality and impulsiveness measures (BIS total, SSS total, 
NEO Conscientiousness, and Delay Discounting ln(k)) for all groups. Delta and theta 
activity showed significant, negative correlations with cigarettes per week (r=−.40, p=.005; 
r=−.31, p=.030), CO levels pre-session (r=−.38, p=.006; r=−.34, p=.017), and FTCD total 
(r=−.34, p=.016; r=−.29, p=.042). Delta activity also showed significant, negative 
correlations with NDSS total (r=−.34, p=.015) and WISDM total (r=−.29, p=.042). A 
Bonferroni correction for the smoking variables set significance levels at p<.002, negating 
the significant exploratory correlations. No significant correlations were found between 
resting EEG measures and impulsiveness variables.
4. Discussion
The present study measured resting EEG response in non-deprived smokers and non-
smokers. Compared to previous studies investigating EEG of smokers without acute drug 
administration or withdrawal effects (Knott and Venables, 1977 Pickworth et al., 1997), this 
study had a larger sample size, included nondaily smokers, included both eyes-closed and 
eyes-open recording conditions, and used a denser electrode montage. Attenuated EEG 
power in daily smokers compared to nonsmokers suggests alterations of neural synchrony 
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that may reflect risk factors for nicotine use and dependence or effects of chronic nicotine 
use.
Daily smokers showed less alpha power during the eyes closed condition and less delta 
power during the eyes open condition than non-smokers. The findings of reduced alpha 
power in daily smokers are consistent with past findings of reduced EEG power during 
nicotine withdrawal, and may explain electrophysiological differences when compared to 
non-smokers. Without comparison to states of acute nicotine administration or abstinence, it 
is difficult to judge whether decreases in power reflect an early withdrawal state, premorbid 
differences in neural response, or neural changes due to chronic nicotine use. In order to 
avoid comparing an acute withdrawal (daily smokers) to groups who do not experience 
withdrawal (nondaily smokers) or do not smoke, non-deprived daily dependent smokers 
were compared to nondaily smokers and non-smokers. Acute nicotine effects were not 
present in nondaily smokers, who showed a non-significant trend of lower alpha (eyes 
closed) response than non-smokers that may be independent of nicotine state. Future studies 
testing daily and nondaily smokers at peak and trough nicotine states using a within-subjects 
design are needed to resolve nicotine effects on resting EEG in dependent and non-
dependent individuals. Comparing effects of nicotine administration on smokers and non-
smokers during EEG recording would demonstrate differential magnitude of change in alpha 
power between groups.
Daily smokers showed less delta and theta power during the eyes open condition and a trend 
for lower alpha power than nondaily smokers. Furthermore, exploratory correlation analyses 
suggested that the electrophysiological responses were sensitive to smoking variables, with 
higher use/dependence correlating with lower EEG power. However, this association did not 
hold when a correction factor was applied. The differences between daily and nondaily 
smokers suggest a potential dose-response effect that merits further investigation. Including 
light and heavy daily smokers in the sample and recording smoking pack-years would 
control for effects of smoking duration across varying smoking rates and may elucidate the 
role of smoking rate and duration on resting EEG response. Adding a measure of evoked 
EEG response may provide an additional evaluation of neural synchrony capacity in daily 
and nondaily smokers. Crawford et al. (2002) measured auditory evoked synchrony and 
found enhanced gamma (40 Hz) response during both abstinent and peak nicotine states in 
chronic, heavy smokers compared to never-smokers. Crawford et al. (2002) attributed group 
differences to acute nicotine effects and chronic inhibition of monoamine oxidase on 
dopamine neurotransmission and gamma synchrony. Impaired gamma synchrony has been 
found in clinical populations with abnormalities in GABA and glutamate neurotransmission 
(e.g., Uhlhaas and Singer, 2006). Resting and evoked EEG measures may be sensitive to 
different smoking rates and states.
Self-report measures of sensation seeking and personality distinguished non-smokers from 
both daily and nondaily smokers. Non-smokers scored lower on disinhibition and experience 
seeking than both smoking groups, consistent with studies showing that sensation seeking is 
associated with increased drug abuse vulnerability and can differentiate smokers and non-
smokers (Kelly et al., 2006, Perkins et al., 2008, Spillane et al., 2010). Lower 
conscientiousness in daily and nondaily smokers is consistent with research identifying low 
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conscientiousness as a risk factor for smoking initiation and maintenance and high 
conscientiousness as a protective factor against smoking (Kashdan et al., 2005, Von Ah et 
al., 2005, Conner et al., 2009) Conscientiousness has been associated with better behavioral 
control, healthy coping strategies, and greater feelings of personal control (Terracciano and 
Costa, 2004, Kashdan et al., 2005, Terracciano et al., 2008, Conner et al., 2009). These 
results support that increased sensation seeking and low conscientiousness may be a risk for 
smoking behavior. In contrast, measures of impulsiveness differentiated non-smokers and 
nondaily smokers from daily smokers. Specifically, daily smokers reported greater motor 
impulsivity than the other groups. Motor impulsivity has been associated with more habit-
driven rather than goal-directed behavior, and associated with risk-taking and impaired 
working memory and executive function (Hogarth et al., 2012). Motor impulsiveness may 
reflect greater dependence and potentiate continued smoking behavior. Additionally, delay 
discounting showed that smokers made more impulsive choices than non-smokers, but daily 
and nondaily smokers discounted delayed rewards at a similar rate.
As expected, nondaily smokers scored lower on all measures of smoking history and 
behavior, including smoking duration, measures of dependence (FTCD, NDSS, WISDM), 
and respiratory CO levels, and they started smoking at an older age. A greater increase in 
craving by daily smokers than nondaily smokers may represent a response to cues and 
expectations rather than abstinence time (Dar et al., 2005, Tiffany et al., 2009, Dar et al., 
2010). One interesting result was from a self-report measure included to reflect experiencing 
decreased reward from natural reinforcers as a consequence of drug use and dependence. 
The Physical Anhedonia Scale (PAS) is a self-report measure assessing the ability to 
experience pleasure from typically rewarding physical stimuli, such as food, sex, and 
environment (Chapman LJ, Chapman JP. Revised physical anhedonia scale. Unpublished 
test. 1978). The PAS differs from past measures of anhedonia used in smoking research 
because it separates sensory pleasure from social experiences and personal interests captured 
by broader scales of hedonic capacity (e.g., Snaith–Hamilton Pleasure Scale). Based on 
previous studies associating increased anhedonia with smoking onset, escalation, persistence 
of dependence, and poor cessation outcomes, we expected dependent, daily smokers to show 
greatest anhedonia (higher scores) (Leventhal et al., 2009, Audrain-McGovern et al., 2012). 
Smokers and non-smokers did not differ, which may indicate that the measure is not 
sensitive to smoking behavior. However, findings of lower anhedonia in nondaily smokers 
compared to non-smokers suggest that nondaily smokers may have a heightened capacity for 
sensory experiences. Low PAS scores suggest that nondaily smokers may retain 
reinforcement from natural reward and experience positive physical stimulation beyond the 
norm. Intermittent smoking may promote continued smoking due reduced development of 
tolerance to pleasurable sensory effects. Alternatively, nondaily smokers may be more prone 
to sensory satiation or saturation following one or fewer cigarettes or reduced adaption to 
aversive consequences of inhaling heat or smoke (e.g., throat irritation, nausea). Future 
studies could include questions targeting physical sensations of smoking, such as taste or 
throat hit. Smoking cessation treatment studies may consider a potential role for sensory 
substitution during initial intervention.
Study results must be considered within the context of an observational study. The study 
design does not allow for differentiation between possible premorbid conditions, such as 
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smoking-related changes in neuronal structure and function and low neuronal excitability, 
that may drive smoking behavior and dependence. The sample consisted of young, relatively 
light smokers, leaving out older longer-term heavy smokers and non-dependent daily 
smokers. Younger smokers might be more resilient and have fewer nicotine-related changes 
due to having less experience with nicotine, resulting in smaller effect sizes and lack of 
significant group differences for other frequency bands. Measuring resting EEG in 
adolescents or adults during smoking initiation may reveal risk factors for future transition 
to daily, dependent smoking. Additionally, strict criteria excluding participants with 
comorbid psychiatric disorders, which commonly occur in smokers, controlled non-nicotine 
contributions to EEG response. This design reduced the potential for contamination to the 
EEG effect by the usual comorbidities found in smokers, while also reducing generalization 
to the typical smoker population. A larger sample size and greater variability in smoking 
history, comorbid diagnoses, gender, and ethnicity would increase statistical power to the 
address these factors.
In conclusion, resting EEG may be a useful marker of risk for nicotine dependence and use 
severity as well as for evaluating relapse risk and treatment efficacy (e.g., nicotine 
replacement therapies and smoking cessation pharmacotherapies) in chronic smokers. 
Vulnerability for initiation and maintenance for smoking behavior may be predicted by 
measures of impulsiveness and conscientiousness, but these personality measures do not 
seem to have a major influence on resting EEG. More research is needed to evaluate the role 
of physical (sensory) anhedonia in smoking behavior and its potential utility in smoking 
cessation treatment.
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HIGHLIGHTS
• Resting EEG in non-deprived smokers may be a biomarker for nicotine use 
severity.
• Smokers report higher impulsiveness and lower conscientiousness than 
nonsmokers.
• Sensory hedonia may play a role in nondaily smoking.
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Figure 1. 
Resting State EEG power spectra for the eyes closed and eyes open conditions across 
groups. Delta: 1.5–3.5 Hz; Theta: 4–7.5 Hz; Alpha: 8–12.5 Hz; Beta (13–25 Hz; Gamma: 
30–45 Hz. Error bars represent ± 1 SEM. The following symbols represent significance: † 
p<.06, *p<.05, **p<.01.
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Figure 2. 
Self-report measure of conscientiousness (scale range: 0 to 48) from the NEO Five Factor 
Inventory across groups. Error bars represent ± 1 SEM. The following symbols represent 
significance: *p<.05, **p<.01.
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Figure 3. 
Self-report measures of impulsivity from the Barratt Impulsiveness Scale (subscale range: 
11 to 44) and the Sensation Seeking Scale (subscale range: 0 to 10) across groups. Error bars 
represent ± 1 SEM. The following symbols represent significance: *p<.05, **p<.01.
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Figure 4. 
Self-report measures of the physical anhedonia across groups (scale range: 0 to 61). Error 
bars represent ± 1 SEM. The following symbols represent significance: *p<.05, **p<.01.
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Figure 5. 
Mean subjective values for non-smokers, nondaily smokers, and daily smokers of an $800 
reward plotted as a function of time from the choice until the receipt of the reward. Trend 
lines show the best-fitting logarithmic function through the mean subjective values for the 
groups.
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